Fate Therapeutics, Inc. (FATE) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Fate Therapeutics, Inc. (FATE): 1Y return 142.0%, Sharpe ratio 1.36, volatility 94.2%, max drawdown -41.8%. A Stock in the Equity asset class. Compare FATE with other assets and invest through your own broker with pfolio.
Fate Therapeutics, Inc. (FATE) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
FATE Performance
- MTD
- Return: 1.3%, Sharpe: 4.52, Volatility: 23.6%, Max Drawdown: -1.2%
- YTD
- Return: 146.9%, Sharpe: 1.80, Volatility: 97.2%, Max Drawdown: -34.6%
- 1Y
- Return: 142.0%, Sharpe: 1.36, Volatility: 94.2%, Max Drawdown: -41.8%
- 5Y
- Return: -96.7%, Sharpe: -0.23, Volatility: 91.9%, Max Drawdown: -99.1%
- 10Y
- Return: 1.7%, Sharpe: 0.43, Volatility: 84.8%, Max Drawdown: -99.4%
Frequently Asked Questions
- What is Fate Therapeutics, Inc. (FATE)?
- Fate Therapeutics, Inc. (FATE) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does FATE compare to other assets?
- You can compare FATE with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in FATE through pfolio?
- pfolio helps you build diversified portfolios that may include FATE. You invest through your own broker — pfolio provides the analytics.